SINGAPORE (May 21): UOB Kay Hian is keeping its “buy” call on Tianjin Zhong Xin Pharmaceutical Group Corporation (TJZX) with an unchanged target price of US$1.72 – representing an upside of 43%.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply